Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a global biopharmaceutical company based in Cambridge, Massachusetts, focused on RNAi therapeutic drug research, development, and commercialization for rare diseases. The firm supports clinical trials, regulatory filings, and commercial supply chains with FDA, EMA, and ISO 13485/9001 compliance controls. Alnylam partners with CROs, contract manufacturers, and healthcare providers for vendor oversight, clinical risk, regulatory auditing, and data privacy. In 2024, Alnylam reported revenues of $1.57 billion, investing in R&D, sustainable supply chain practices, and compliance management for pharmaceutical innovation.
Alnylam Pharmaceuticals Overview
- Company: Alnylam Pharmaceuticals
- Industry: Pharmaceuticals
- Employees: 1,001-5,000
- Location: 675 W Kendall St, Cambridge, MA 02142, USA
- Founded: 2002
Alnylam Pharmaceuticals Certifications and Compliance
Through Panorays' Attack Surface Assessments, you can view all identified published certifications, providing a clearer and more accurate understanding of your compliance status
Alnylam Pharmaceuticals Cyber Related News
Access business-specific cyber news from diverse sources, all categorized and consolidated in one place, ensuring clear visibility into cyber events and incidents relevant to your organization.
#0
No relevant cyber news available at this time.
Alnylam Pharmaceuticals External Attack Surface Geolocation Map
Gain detailed insights into the location of your assets through our comprehensive external assessments.
Alnylam Pharmaceuticals Supply Chain Discovery
Supply Chain Discovery identifies Nth-party connections to your company, maps their relationships, and continuously monitors them for cyber threats. The following graph segments detected third parties according to their Cyber Posture Rating.
Alnylam Pharmaceuticals Cyber Posture Rating
Alnylam Pharmaceuticals security rating reflects the analysis of its external attack surface. A higher rating indicates a stronger security posture. Begin a free trial to receive a comprehensive risk assessment for Alnylam Pharmaceuticals.
Is this your company? Claim your security score now.
NA
Alnylam Pharmaceuticals Category Breakdown
Human
Employee
NA
Security Team
NA
Social Posture
NA
Dynamics
NA
Application
Techs
NA
Application Security
NA
Domain Attacks
NA
Exposed Services
NA
IT
DNS
NA
Mail Server
NA
Asset Reputation
NA
Web Server
NA
TLS
NA
Cloud
NA
Endpoint
NA
Panorays Named a Leader in The Forrester Wave™ in Cybersecurity Risk Ratings Platforms, Q2 2024
“Panorays best fits enterprise TPRM programs”
Is your organization secure?
Discover critical risks and vulnerabilities in your supply chain with our comprehensive report.